Learn More
Tocris Bioscience™ UBP 310
GluK1-selective kainate antagonist
POA
Description
GluK1 (formerly GLUK5) kainate receptor antagonist (IC50 = 130 nM); also blocks recombinant homomeric GluK3 (forrmerly GLUK7) receptors. Displays 12,700-fold selectivity for GluK1 (formerly GLUK5) over GluK2 (formerly GLUK6). Exhibits no activity at mGlu group I or NMDA receptors at concentrations of up to 10 μM. Apparent KD value is 18 ± 4 nM for depression of kainate responses on the dorsal root.Please refer to IUPHAR Guide to Pharmacology for the most recent naming conventions.
Specifications
>98% |
For Research Use Only